These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2874680

  • 1. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
    Iitaka M, Tanikawa T, Sakatsume Y, Yanagisawa M, Hara Y, Ishii J.
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
    [Abstract] [Full Text] [Related]

  • 2. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y, Hamazu M, Kajita Y, Nagata A.
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [Abstract] [Full Text] [Related]

  • 3. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
    Akamizu T, Mori T, Kasagi K, Kosugi S, Miyamoto M, Nishino K, Sugawa H, Yokota T, Nakamura H, Konishi J.
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
    [Abstract] [Full Text] [Related]

  • 4. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors.
    de Bruin TW, van der Heide D.
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495
    [Abstract] [Full Text] [Related]

  • 5. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J, Hamada N, Saito H, Oyanagi H, Ishikawa N, Momotani N, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [Abstract] [Full Text] [Related]

  • 6. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK.
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of auto-antibodies to bovine TSH in the serum of two patients with Graves' disease.
    Kajita Y, Nakajima Y, Ishida M, Ochi Y, Miyazaki T, Hachiya T, Ijichi H.
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):423-30. PubMed ID: 6318490
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M, Nakao Y, Baba Y, Kobayashi N, Matsukura S, Kuma K, Fujita T.
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [Abstract] [Full Text] [Related]

  • 11. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
    Creagh FM, Howells RD, Williams S, Didcote S, Hashim FA, Petersen VB, Rees Smith B.
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y, Ishihara T, Ikekubo K, Mori T.
    Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
    [Abstract] [Full Text] [Related]

  • 16. Thyrotropin-receptor autoantibodies in children and young adults with Graves' disease.
    Brown RS, Kertiles LP, Rosenfield C, Kleinmann RE, Crigler JF.
    Am J Dis Child; 1986 Mar; 140(3):238-41. PubMed ID: 2868651
    [Abstract] [Full Text] [Related]

  • 17. Antithyrotropin antibodies in the sera of Graves' disease patients.
    Raines KB, Baker JR, Lukes YG, Wartofsky L, Burman KD.
    J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
    [Abstract] [Full Text] [Related]

  • 18. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y, Kajita Y, Hamazu M, Nagata A.
    Horm Res; 2003 Aug; 59(5):222-8. PubMed ID: 12714785
    [Abstract] [Full Text] [Related]

  • 19. TSH receptor binding and thyroid stimulation by sera from patients with Graves' disease.
    Ginsberg J, Shewring G, Smith BR.
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):305-11. PubMed ID: 6138173
    [Abstract] [Full Text] [Related]

  • 20. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T, Villadolid MC, Ingbar SH.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.